NCT00117351View on ClinicalTrials.gov

VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features

PHASE2TerminatedINTERVENTIONAL
Timeline

Start Date

April 30, 2005

Primary Completion Date

June 30, 2007

Study Completion Date

July 31, 2007

Conditions
Carcinoma, Non-Small-Cell LungAdenocarcinoma, Bronchiolo-Alveolar
Interventions
DRUG

VELCADE

Trial Locations (1)

98104

Swedish Cancer Institute, Seattle

Sponsors
All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY